Outcome of acute mesenteric ischaemia in patients with Covid-19 infection

Data on acute mesenteric ischaemia (AMI) in patients with Covid-19 are limited. We studied the clinical profile and outcome of patients presenting and treated for AMI and Covid-19 infection. This retrospective, observational study was done at a single tertiary care centre in India from May 2021 to April 2022. Ten patients (8 males; median age 57 years) with confirmed Covid-19 and AMI diagnosed on the basis of clinical and radiological criteria were included in the analysis. Associated comorbid conditions were present in 8 of 10 patients. The median interval from diagnosis of Covid-19 to onset of gastrointestinal symptoms was 11 days, with abdominal pain being the most common. Seven patients underwent surgical resection, while 3 patients were managed conservatively. Two patients were on antithrombotics before the development of AMI and had less severe involvement. Four patients died in hospital. AMI in Covid-19 infection is associated with morbidity and mortality. Previous antithrombotic use does not prevent the development of AMI but possibly reduces its severity.